Ardent Health Partners, Inc. (ARDT)
NYSE: ARDT · Real-Time Price · USD
14.86
+0.34 (2.34%)
May 12, 2025, 3:37 PM - Market open
Ardent Health Partners Stock Forecast
Stock Price Forecast
The 13 analysts with 12-month price forecasts for Ardent Health Partners stock have an average target of 20.85, with a low estimate of 18 and a high estimate of 25. The average target predicts an increase of 40.31% from the current stock price of 14.86.
Analyst Consensus: Buy
Analyst Ratings
The average analyst rating for Ardent Health Partners stock from 13 stock analysts is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
Rating | Dec '24 | Jan '25 | Feb '25 | Mar '25 | Apr '25 | May '25 |
---|---|---|---|---|---|---|
Strong Buy | 2 | 2 | 2 | 2 | 3 | 3 |
Buy | 6 | 6 | 7 | 7 | 7 | 7 |
Hold | 3 | 3 | 3 | 3 | 3 | 3 |
Sell | 0 | 0 | 0 | 0 | 0 | 0 |
Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
Total | 11 | 11 | 12 | 12 | 13 | 13 |
Latest Forecasts
Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
---|---|---|---|---|---|---|---|
Guggenheim | Guggenheim | Strong Buy Maintains $16 → $18 | Strong Buy | Maintains | $16 → $18 | +21.13% | May 9, 2025 |
Guggenheim | Guggenheim | Strong Buy Initiates $16 | Strong Buy | Initiates | $16 | +7.67% | Apr 9, 2025 |
Mizuho | Mizuho | Buy Maintains $19 → $18 | Buy | Maintains | $19 → $18 | +21.13% | Apr 9, 2025 |
Stephens & Co. | Stephens & Co. | Buy Reiterates $22 | Buy | Reiterates | $22 | +48.05% | Apr 1, 2025 |
Stephens & Co. | Stephens & Co. | Buy Reiterates $22 | Buy | Reiterates | $22 | +48.05% | Mar 26, 2025 |
Financial Forecast
Revenue This Year
6.45B
from 5.97B
Increased by 8.18%
Revenue Next Year
6.81B
from 6.45B
Increased by 5.58%
EPS This Year
1.93
from 1.58
Increased by 22.17%
EPS Next Year
2.03
from 1.93
Increased by 5.35%
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
Revenue | 2025 | 2026 | 2027 |
---|---|---|---|
High | 6.7B | 7.1B | 7.5B |
Avg | 6.5B | 6.8B | 7.2B |
Low | 6.2B | 6.5B | 6.9B |
Revenue Growth
Revenue Growth | 2025 | 2026 | 2027 |
---|---|---|---|
High | 11.8% | 9.4% | 9.8% |
Avg | 8.2% | 5.6% | 5.5% |
Low | 3.7% | 1.1% | 0.6% |
EPS Forecast
EPS | 2025 | 2026 | 2027 |
---|---|---|---|
High | 2.09 | 2.35 | 2.43 |
Avg | 1.93 | 2.03 | 2.21 |
Low | 1.77 | 1.80 | 1.99 |
EPS Growth
EPS Growth | 2025 | 2026 | 2027 |
---|---|---|---|
High | 32.2% | 21.8% | 19.3% |
Avg | 22.2% | 5.4% | 8.5% |
Low | 12.3% | -6.6% | -2.2% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.